Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $260.30 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $83.14 | 4 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $38.77 | 2 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $38.55 | 2 | $0 (2024) |
| Pacira Pharmaceuticals Incorporated | $26.57 | 1 | $0 (2024) |
| Antares Pharma, Inc. | $21.57 | 1 | $0 (2024) |
| Lilly USA, LLC | $19.31 | 1 | $0 (2024) |
| Amgen Inc. | $18.34 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $14.05 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248.04 | 12 | ABBVIE INC. ($70.88) |
| 2021 | $12.26 | 1 | AbbVie Inc. ($12.26) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.05 | General |
| Category: Opioid Analgesic | ||||||
| 11/08/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: Opioid Analgesic | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Analgesic | ||||||
| 07/03/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/25/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Pain Management | ||||||
| 06/20/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Analgesic | ||||||
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.05 | General |
| 02/28/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/11/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Diabetes | ||||||
| 09/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 256 | 710 | $22,417 | $11,331 |
| 2022 | 6 | 100 | 214 | $6,520 | $3,566 |
| 2021 | 3 | 51 | 152 | $4,128 | $2,158 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 109 | $14,930 | $7,518 | 50.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $1,675 | $1,317 | 78.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 17 | 38 | $760.00 | $616.36 | 81.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 15 | 17 | $786.00 | $588.54 | 74.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 89 | $2,670 | $570.05 | 21.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 55 | $418.00 | $348.60 | 83.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 19 | $380.00 | $164.15 | 43.2% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 15 | 33 | $294.00 | $163.03 | 55.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 16 | 68 | $272.00 | $19.94 | 7.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 12 | 39 | $117.00 | $12.74 | 10.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 28 | 230 | $115.00 | $12.36 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 27 | $3,510 | $2,063 | 58.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 12 | $1,080 | $623.72 | 57.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 16 | 17 | $782.00 | $591.04 | 75.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 34 | $1,020 | $246.72 | 24.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 11 | 12 | $72.00 | $32.55 | 45.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 15 | 112 | $56.00 | $8.97 | 16.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 24 | $3,120 | $1,932 | 61.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 19 | 32 | $960.00 | $218.36 | 22.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 12 | 96 | $48.00 | $7.39 | 15.4% |
About Blake Hand, CRNP
Blake Hand, CRNP is a Registered Nurse healthcare provider based in Gardendale, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2019. The National Provider Identifier (NPI) number assigned to this provider is 1215496708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Blake Hand, CRNP has received a total of $260.30 in payments from pharmaceutical and medical device companies, with $248.04 received in 2024. These payments were reported across 13 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($260.30).
As a Medicare-enrolled provider, Hand has provided services to 407 Medicare beneficiaries, totaling 1,076 services with total Medicare billing of $17,056. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Gardendale, AL
- Active Since 03/14/2019
- Last Updated 11/12/2024
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215496708
Products in Payments
- QULIPTA (Drug) $54.38
- ZTLido (Drug) $38.77
- XTAMPZA (Drug) $38.55
- Exparel (Drug) $26.57
- XYOSTED (Drug) $21.57
- JARDIANCE (Drug) $19.31
- KRYSTEXXA (Biological) $18.34
- BOTOX (Biological) $16.50
- VRAYLAR (Drug) $12.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Gardendale
Jeremy Hale, Rn, RN
Registered Nurse
Jennifer Ware, Dnp, Fnp-C, DNP, FNP-C
Registered Nurse
Anderica Gunnerson
Registered Nurse
Erin Henley
Registered Nurse
Lee Hargett
Registered Nurse
Rhyann Taylor
Registered Nurse